FIELD: chemistry.
SUBSTANCE: disclosed is an agent which is one of the derivatives of N-substituted 1,4-diazabicyclo[2.2.2.]octane, which exhibits antiviral activity on DNA viruses. The disclosed agent can be used in veterinary and healthcare.
EFFECT: higher antiviral activity towards DNA viruses.
6 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT HAVING ANTIVIRAL ACTIVITY | 2008 |
|
RU2402563C2 |
AGENT SHOWING ANTIVIRAL ACTIVITY ON DNA-VIRUSES | 2012 |
|
RU2487876C1 |
N-SUBSTITUTED 1,4-DIAZABICYCLO-[2,2,2]-OCTANE DERIVATIVES EXHIBITING RNA-ANTIVIRAL ACTIVITY | 2008 |
|
RU2399669C2 |
POLYCATIONIC TRIVIRON COMPOUND AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2527256C1 |
METHOD OF TREATING POULTRY WITH POLYCATIONIC TRIVIRON COMPOUND | 2013 |
|
RU2532355C1 |
AGENT HAVING ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2443705C1 |
AGENT FOR INACTIVATION OF VIRUSES EXHIBITING SIMULTANEOUS RIBONUCLEASE, MEMBRANOLYTIC AND ANTIVIRAL ACTIVITIES | 2008 |
|
RU2399388C2 |
CIPROFLOXACIN DERIVATIVE WITH ANTIBACTERIAL ACTIVITY AGAINST ANTIBIOTIC-RESISTANT STRAINS OF MICROORGANISMS | 2021 |
|
RU2757741C1 |
DERIVATIVES OF HEMIN AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD FOR PREPARING, APPLICATION AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2238950C2 |
HEMIN-PEPTIDE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND USING AS ANTI-VIRAL AND VIRULICIDE AGENT | 2004 |
|
RU2296131C2 |
Authors
Dates
2013-04-27—Published
2012-02-29—Filed